Showing results (71-80 of 259) with videos related to
Sort By:
Pageof 26
Scientific Reports|November 11, 2024
Phase 1 study of isatuximab monotherapy in Chinese patients with relapsed/refractory multiple myelomaMingyuan Sun, Hongmei Jing, Xiaoyan Qu, et al.The Journal of Clinical Investigation|June 5, 2018
Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myelomaReinaldo Franqui-Machin, Mu Hao, Hua Bai, et al.Leukemia & Lymphoma|December 8, 2010
TOSO is overexpressed and correlated with disease progression in Chinese patients with chronic lymphocytic leukemiaShuhua Yi, Zhen Yu, Keshu Zhou, et al.Current Medical Research and Opinion|February 13, 2026
Zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: health-related quality of life in a subgroup of Chinese patients in the ALPINE trialConstantine S Tam, Mazyar Shadman, Shin Yeu Ong, et al.Blood|July 16, 2016
Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implicationGang An, Chirag Acharya, Xiaoyan Feng, et al.International Journal of Cancer|September 16, 2014
Low serum miR-19a expression as a novel poor prognostic indicator in multiple myelomaMu Hao, Meirong Zang, Erik Wendlandt, et al.BMC Cancer|July 30, 2015
Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: long-term results from a single center in ChinaZengjun Li, Fei Li, Shuhua Yi, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 3, 2015
[Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma]Dehui Zou, Shuhua Yi, Huimin Liu, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 3, 2015
[Autologous hematopoietic stem cell transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: a single center experience from the BDHALL2000/02 protocol]Tingyu Wang, Dehui Zou, Yanru Zhang, et al.Ebiomedicine|January 10, 2024
CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagyPeixia Tang, Zhen Yu, Hao Sun, et al.Pageof 26